Introduction:
The OLMIDIP range offers a comprehensive selection of antihypertensive therapies centered around Olmesartan medoxomil, a potent and long-acting angiotensin II receptor blocker (ARB). These formulations are designed to provide optimal blood pressure control either as monotherapy or in combination with Amlodipine or Hydrochlorothiazide for enhanced efficacy. OLMIDIP is ideal for patients requiring consistent 24-hour BP coverage and organ protection.
Available in ALU-ALU or Aluminium Foil packaging (10 x 10 tablets) for product integrity and patient convenience.
Product Variants & Composition:
TAB OLMIDIP-20
Composition: Olmesartan medoxomil 20 mg
Packaging: ALU-ALU | 10 x 10 Tablets
TAB OLMIDIP-20 A
Composition: Olmesartan medoxomil 20 mg + Amlodipine 5 mg
Packaging: Aluminium Foil | 10 x 10 Tablets
TAB OLMIDIP-20 H
Composition: Olmesartan medoxomil 20 mg + Hydrochlorothiazide 12.5 mg
Packaging: ALU-ALU | 10 x 10 Tablets
TAB OLMIDIP-40
Composition: Olmesartan medoxomil 40 mg
Packaging: ALU-ALU | 10 x 10 Tablets
TAB OLMIDIP-40 H
Composition: Olmesartan medoxomil 40 mg + Hydrochlorothiazide 12.5 mg
Packaging: ALU-ALU | 10 x 10 Tablets
Key Benefits:
-
Long-acting ARB for consistent 24-hour BP control
-
Organ-protective effects, especially in diabetic nephropathy
-
Lower incidence of cough compared to ACE inhibitors
-
Dual and triple combinations for personalized therapy in moderate to severe hypertension
-
Once-daily dosing enhances compliance
-
Excellent tolerability in elderly and metabolic syndrome patients
Indications:
-
Essential hypertension (mild to severe)
-
High cardiovascular risk or diabetic patients
-
Combination therapy for patients uncontrolled on monotherapy
-
Kidney protection in hypertensive diabetics
Dosage & Administration:
-
OLMIDIP-20 / OLMIDIP-40: One tablet once daily; dose titrated based on BP response
-
OLMIDIP-20 A / 20 H / 40 H: One tablet once daily, preferably in the morning
-
Can be taken with or without food
-
Monitor BP, renal function, and electrolytes periodically
Precautions & Warnings:
-
Avoid in pregnancy (Category D)
-
Monitor for hyperkalemia, especially in renal impairment or when used with potassium-sparing drugs
-
Use caution in patients with volume depletion or severe hepatic dysfunction
-
Diuretic combinations may require periodic electrolyte monitoring
Possible Side Effects:
-
Dizziness, fatigue, or headache
-
Hyperkalemia or slight elevation in creatinine
-
With Amlodipine: peripheral edema, flushing
-
With Hydrochlorothiazide: electrolyte imbalance, increased urination, photosensitivity
Conclusion:
The OLMIDIP range provides a flexible and effective approach to hypertension management, offering tailored monotherapy and combination options. Backed by Olmesartan’s robust clinical profile, OLMIDIP helps achieve optimal BP goals, reduce cardiovascular risk, and enhance renal protection.
Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category Cardiac
You can also contact us https://diabetes-cardiac.com/contact-us/
